BMI · Badger Meter Inc
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Scientific & Technical Instruments — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BMI
this stock
Badger Meter Inc
|
$3.69B | -27.6% | +10.9% | 29.7 | 15.8% |
|
KEYS
Keysight Technologies, Inc.
|
$56.39B | +65.3% | +8.0% | 45.4 | 1.4% |
|
GRMN
Garmin Ltd
|
$54.92B | +41.1% | +15.1% | 29.4 | 1.7% |
|
COHR
Coherent Corp.
|
$45.44B | +25.7% | +19.2% | 56.3 | 5.6% |
|
TDY
Teledyne Technologies Inc
|
$28.68B | +21.3% | -4.6% | 29.9 | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BMI | -4.6% | -4.0% | +6.6% | +2.2% | -27.6% |
| SPY | -1.5% | -0.9% | +7.7% | +0.5% | +12.4% |
| vs SPY | -3.1% | -3.1% | -1.1% | +1.7% | -40.0% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.